An Updated Systematic Review of Cost-Effectiveness Analyses of Drugs for Osteoporosis.
Li N, Cornelissen D, Silverman S, Pinto D, Si L, Kremer I, Bours S, de Bot R, Boonen A, Evers S, van den Bergh J, Reginster JY, Hiligsmann M.
Li N, et al.
Pharmacoeconomics. 2021 Feb;39(2):181-209. doi: 10.1007/s40273-020-00965-9. Epub 2020 Oct 7.
Pharmacoeconomics. 2021.
PMID: 33026634
Free PMC article.